225 related articles for article (PubMed ID: 26861725)
1. Inhaled Biologics: From Preclinical to Product Approval.
Fathe K; Ferrati S; Moraga-Espinoza D; Yazdi A; Smyth HD
Curr Pharm Des; 2016; 22(17):2501-21. PubMed ID: 26861725
[TBL] [Abstract][Full Text] [Related]
2. Challenges and Future Prospects for the Delivery of Biologics: Oral Mucosal, Pulmonary, and Transdermal Routes.
Morales JO; Fathe KR; Brunaugh A; Ferrati S; Li S; Montenegro-Nicolini M; Mousavikhamene Z; McConville JT; Prausnitz MR; Smyth HDC
AAPS J; 2017 May; 19(3):652-668. PubMed ID: 28194704
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive delivery strategies for biologics.
Anselmo AC; Gokarn Y; Mitragotri S
Nat Rev Drug Discov; 2019 Jan; 18(1):19-40. PubMed ID: 30498202
[TBL] [Abstract][Full Text] [Related]
4. Oral inhalation for delivery of proteins and peptides to the lungs.
Fröhlich E; Salar-Behzadi S
Eur J Pharm Biopharm; 2021 Jun; 163():198-211. PubMed ID: 33852968
[TBL] [Abstract][Full Text] [Related]
5. Dosing considerations for inhaled biologics.
Ferrati S; Wu T; Kanapuram SR; Smyth HDC
Int J Pharm; 2018 Oct; 549(1-2):58-66. PubMed ID: 30053488
[TBL] [Abstract][Full Text] [Related]
6. Inspiration and Exasperation: The Challenges of Inhaled Biologics.
Hall P; Vahle JL; Colman K
Toxicol Pathol; 2021 Feb; 49(2):232-234. PubMed ID: 33397211
[TBL] [Abstract][Full Text] [Related]
7. Practical considerations in clinical strategy to support the development of injectable drug-device combination products for biologics.
Li Z; Easton R
MAbs; 2018 Jan; 10(1):18-33. PubMed ID: 29035675
[TBL] [Abstract][Full Text] [Related]
8. In Vitro Pulmonary Cell Culture in Pharmaceutical Inhalation Aerosol Delivery: 2-D, 3-D, and In Situ Bioimpactor Models.
Acosta MF; Muralidharan P; Meenach SA; Hayes D; M-Black S; Mansour HM
Curr Pharm Des; 2016; 22(17):2522-31. PubMed ID: 26831643
[TBL] [Abstract][Full Text] [Related]
9. Inhalation delivery of protein therapeutics.
Kane C; O'Neil K; Conk M; Picha K
Inflamm Allergy Drug Targets; 2013 Apr; 12(2):81-7. PubMed ID: 23517644
[TBL] [Abstract][Full Text] [Related]
10. Oral Delivery of Biologics for Precision Medicine.
Durán-Lobato M; Niu Z; Alonso MJ
Adv Mater; 2020 Apr; 32(13):e1901935. PubMed ID: 31222910
[TBL] [Abstract][Full Text] [Related]
11. Challenges in inhaled product development and opportunities for open innovation.
Forbes B; Asgharian B; Dailey LA; Ferguson D; Gerde P; Gumbleton M; Gustavsson L; Hardy C; Hassall D; Jones R; Lock R; Maas J; McGovern T; Pitcairn GR; Somers G; Wolff RK
Adv Drug Deliv Rev; 2011; 63(1-2):69-87. PubMed ID: 21144875
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in oral delivery of biologics: nanomedicine and physical modes of delivery.
Vllasaliu D; Thanou M; Stolnik S; Fowler R
Expert Opin Drug Deliv; 2018 Aug; 15(8):759-770. PubMed ID: 30033780
[TBL] [Abstract][Full Text] [Related]
13. Overview and Future Potential of Buccal Mucoadhesive Films as Drug Delivery Systems for Biologics.
Montenegro-Nicolini M; Morales JO
AAPS PharmSciTech; 2017 Jan; 18(1):3-14. PubMed ID: 27084567
[TBL] [Abstract][Full Text] [Related]
14. Improving the efficacy of inhaled drugs in cystic fibrosis: challenges and emerging drug delivery strategies.
d'Angelo I; Conte C; La Rotonda MI; Miro A; Quaglia F; Ungaro F
Adv Drug Deliv Rev; 2014 Aug; 75():92-111. PubMed ID: 24842473
[TBL] [Abstract][Full Text] [Related]
15. The ascent of pulmonary drug delivery.
Gonda I
J Pharm Sci; 2000 Jul; 89(7):940-5. PubMed ID: 10861595
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary delivery of opioids as pain therapeutics.
Farr SJ; Otulana BA
Adv Drug Deliv Rev; 2006 Oct; 58(9-10):1076-88. PubMed ID: 17070614
[TBL] [Abstract][Full Text] [Related]
17. Preclinical models for pulmonary drug delivery.
Fernandes CA; Vanbever R
Expert Opin Drug Deliv; 2009 Nov; 6(11):1231-45. PubMed ID: 19852680
[TBL] [Abstract][Full Text] [Related]
18. Newer devices and improved formulations of inhaled insulin.
Rashid J; Absar S; Nahar K; Gupta N; Ahsan F
Expert Opin Drug Deliv; 2015 Jun; 12(6):917-28. PubMed ID: 25485886
[TBL] [Abstract][Full Text] [Related]
19. Delivery Technologies for Orally Inhaled Products: an Update.
Moon C; Smyth HDC; Watts AB; Williams RO
AAPS PharmSciTech; 2019 Feb; 20(3):117. PubMed ID: 30783904
[TBL] [Abstract][Full Text] [Related]
20. Drug metabolism in the lungs: opportunities for optimising inhaled medicines.
Enlo-Scott Z; Bäckström E; Mudway I; Forbes B
Expert Opin Drug Metab Toxicol; 2021 May; 17(5):611-625. PubMed ID: 33759677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
